Multiple sclerosis: basic knowledge and new insights in perioperative management

被引:0
|
作者
Alexandros Makris
Alexandros Piperopoulos
Iosifina Karmaniolou
机构
[1] Asklepieion Hospital of Voula,Department of Anesthesiology
[2] Royal National Orthopaedic Hospital,Department of Anesthesia
来源
Journal of Anesthesia | 2014年 / 28卷
关键词
Multiple sclerosis; General anesthesia; Regional anesthesia;
D O I
暂无
中图分类号
学科分类号
摘要
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system affecting young adults that may lead to significant disability. The clinical course varies among the types of the disease as well as among individuals. Herein we provide a brief review of the recent data concerning the clinical presentation, diagnosis, causes, and pathogenesis of MS as well as medication used, followed by the anesthetic considerations of patients diagnosed with the disease. To accomplish this, we conducted a systematic PubMed literature search for articles, using the terms multiple sclerosis, anesthesia, general, regional, perioperative, and preoperative, and we then manually reviewed the references from each pertinent article. Because randomized controlled trials on the field are rare, most information is derived by case reports and case series. We concluded that the disease itself as well as the treatment modalities may have several implications in the conduct of anesthesia and perioperative management of MS patients. General and regional anesthetic techniques have been successfully used. With thorough preoperative evaluation and in depth knowledge of the disease and its complications, the MS patients can be managed safely.
引用
收藏
页码:267 / 278
页数:11
相关论文
共 50 条
  • [41] MULTIPLE-SCLEROSIS - NEW INSIGHTS FROM OLD TOOLS
    EBERS, GC
    MAYO CLINIC PROCEEDINGS, 1993, 68 (07) : 711 - 712
  • [42] Understanding fatigue in multiple sclerosis: new insights in causes and assessment
    B. Colombo
    P. Annovazzi
    G. Comi
    Neurological Sciences, 2006, 27 : s304 - s306
  • [43] New insights into the pathology of multiple sclerosis: towards a unified concept?
    Wolfgang Brück
    Journal of Neurology, 2007, 254 : I3 - I9
  • [44] Insights into the immunopathogenesis of multiple sclerosis
    Niels Hellings
    Jef Raus
    Piet Stinissen
    Immunologic Research, 2002, 25 : 27 - 51
  • [45] Insights into the immunopathogenesis of multiple sclerosis
    Hellings, N
    Raus, J
    Stinissen, P
    IMMUNOLOGIC RESEARCH, 2002, 25 (01) : 27 - 51
  • [46] New master's program: Multiple Sclerosis Management
    Voigt, I.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 351 - 351
  • [47] Dalfampridine: A new agent for symptomatic management of multiple sclerosis
    McDonald, Sarah
    Clements, Jennifer N.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (24) : 2335 - 2340
  • [48] NEW ADVANCES IN SYMPTOM MANAGEMENT IN MULTIPLE-SCLEROSIS
    SCHAPIRO, RT
    CLINICAL NEUROSCIENCE, 1994, 2 (3-4) : 266 - 270
  • [49] New master's program: multiple sclerosis management
    Voigt, Isabel
    Stadelmann, Christine
    Meuth, Sven G.
    Schipp, Bernhard
    Flachenecker, Peter
    Maeurer, Mathias
    Funk, Richard H. W.
    Ramisch, Franziska
    Niemeier, Joachim
    Ziemssen, Tjalf
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (15-16) : 383 - 391
  • [50] Current knowledge of multiple sclerosis
    Michiels, Yves
    ACTUALITES PHARMACEUTIQUES, 2018, 57 (573): : 24 - 25